NeuroActiva, Inc. Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

NeuroActiva, Inc. is a clinical-stage biotechnology company based in Mountain View, California, focused on discovering and developing new drugs to treat Alzheimer's disease. As a wholly owned subsidiary of Biomed Industries, the company emphasizes advancing therapies from discovery through development toward commercialization. Its pipeline includes NA-831, also known as Traneurocin, an orally administered candidate that has progressed to Phase 2A with demonstrated safety and efficacy, and NA-704, or Vineurocin, given intravenously to support neuroprotection and neurogenesis. NA-831 and NA-704 target neural repair and neurotransmission to address cognitive symptoms associated with Alzheimer's disease, alongside an intravenous delivery platform, the MICROS Infusion System, approved for marketing in the United States to support controlled dosing in clinical and homecare settings. The company’s activities span platform development for neuronal regeneration and systemic delivery approaches, aligning with its position in the biotechnology research sector.

Sign up for free to view info

Company overview Employee directory